Advertising Disclaimer
Published online June 1, 2006
PEDIATRICS Vol. 117 No. 6 June 2006, pp. 2040-2046 (doi:10.1542/peds.2005-1328)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nikles, C. J.
Right arrow Articles by McNairn, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nikles, C. J.
Right arrow Articles by McNairn, N.
Related Collections
Right arrow Developmental/Behavior
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

An n-of-1 Trial Service in Clinical Practice: Testing the Effectiveness of Stimulants for Attention-Deficit/Hyperactivity Disorder

C. Jane Nikles, MBBSa, Geoffrey K. Mitchell, PhDa, Chris B. Del Mar, MDb, Alexandra Clavarino, PhDc, Norma McNairn, BSNa

a Discipline of General Practice
c School of Population Health, The University of Queensland, Herston, Queensland, Australia
b Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Queensland, Australia

OBJECTIVE. We sought to describe the clinical use of n-of-1 trials for attention-deficit/hyperactivity disorder in publicly and privately funded family and specialized pediatric practice in Australia.

METHODS. We used a within-patient randomized, double-blind, crossover comparison of stimulant (dexamphetamine or methylphenidate) versus placebo or alternative stimulant using 3 pairs of treatment periods. Trials were conducted from a central location using mail and telephone communication, with local supervision by the patients’ clinicians.

PATIENTS. Our study population included children with clinically diagnosed attention-deficit/hyperactivity disorder who were aged 5 to 16 years and previously stabilized on an optimal dose of stimulant. They were selected because treatment effectiveness was uncertain.

MAIN OUTCOME MEASURES. Our measures included number of patients recruited, number of doctors who used the service, geographic spread, completion rates, response rate, and post–n-of-1 trial decisions.

RESULTS. Forty-five doctors across Australia requested 108 n-of-1 trials, of which 86 were completed. In 69 drug-versus-placebo comparisons, 29 children responded better to stimulant than placebo. Immediately posttrial, 19 of 25 drug-versus-placebo responders stayed on the same stimulant, and 13 of 24 nonresponders ceased or switched stimulants. In 40 of 63 for which data were available, posttrial management was consistent with the trial results. For all types of n-of-1 trials, management changed for 28 of 64 children for whom information was available.

DISCUSSION. Attention-deficit/hyperactivity disorder n-of-1 trials can be implemented successfully by mail and telephone communication. This type of trial can be valuable in clarifying treatment effect when it is uncertain, and in this series, they had a noticeable impact on short-term management.

Key Words: n-of-1 trials • attention-deficit/hyperactivity disorder

Abbreviations: ADHD—attention-deficit/hyperactivity disorder • DSM-IV—Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition

Accepted Nov 15, 2005.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Palliat MedHome page
J. Nikles, G. Mitchell, J. Walters, J. Hardy, P. Good, D. Rowett, T. Shelby-James, and D. Currow
Prioritising drugs for single patient (n-of-1) trials in palliative care
Palliative Medicine, October 1, 2009; 23(7): 623 - 634.
[Abstract] [PDF]

Home page
 PediatricsHome page
J. N. Epstein, J. M. Langberg, P. K. Lichtenstein, B. A. Mainwaring, C. P. Luzader, and L. J. Stark
Community-wide Intervention to Improve the Attention-Deficit/Hyperactivity Disorder Assessment and Treatment Practices of Community Physicians
Pediatrics, July 1, 2008; 122(1): 19 - 27.
[Abstract] [Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
J. N. Epstein, D. Rabiner, D. E. Johnson, D. P. FitzGerald, A. Chrisman, A. Erkanli, K. K. Sullivan, J. S. March, P. Margolis, E. C. Norton, et al.
Improving Attention-Deficit/Hyperactivity Disorder Treatment Outcomes Through Use of a Collaborative Consultation Treatment Service by Community-Based Pediatricians: A Cluster Randomized Trial
Arch Pediatr Adolesc Med, September 1, 2007; 161(9): 835 - 840.
[Abstract] [Full Text] [PDF]

Home page
 JWatch PediatricsHome page
Are n-of-1 Trials Useful in ADHD Treatment?
Journal Watch Pediatrics and Adolescent Medicine, August 30, 2006; 2006(830): 1 - 1.
[Full Text]